These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29721668)

  • 1. Physician interpretation of variants of uncertain significance.
    Macklin SK; Jackson JL; Atwal PS; Hines SL
    Fam Cancer; 2019 Jan; 18(1):121-126. PubMed ID: 29721668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding variants of uncertain significance in the era of multigene panels: Through the eyes of the patient.
    Reuter C; Chun N; Pariani M; Hanson-Kahn A
    J Genet Couns; 2019 Aug; 28(4):878-886. PubMed ID: 31050105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical interpretation and recommendations for patients with a variant of uncertain significance in BRCA1 or BRCA2: a survey of genetic counseling practice.
    Petrucelli N; Lazebnik N; Huelsman KM; Lazebnik RS
    Genet Test; 2002; 6(2):107-13. PubMed ID: 12215249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and interpretation of a variant of uncertain significance (VUS) genetic test result by pediatric providers who do not specialize in genetics.
    Menke C; Nagaraj CB; Dawson B; He H; Tawde S; Wakefield EG
    J Genet Couns; 2021 Dec; 30(6):1559-1569. PubMed ID: 33969574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification and Clinical Management of Variants of Uncertain Significance in High Penetrance Cancer Predisposition Genes.
    Moghadasi S; Eccles DM; Devilee P; Vreeswijk MP; van Asperen CJ
    Hum Mutat; 2016 Apr; 37(4):331-6. PubMed ID: 26777316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' perspectives of variants of uncertain significance and strategies for uncertainty management.
    Makhnoon S; Shirts BH; Bowen DJ
    J Genet Couns; 2019 Apr; 28(2):313-325. PubMed ID: 30636062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.
    Solomon I; Harrington E; Hooker G; Erby L; Axilbund J; Hampel H; Semotiuk K; Blanco A; Klein WMP; Giardiello F; Leonard L
    J Genet Couns; 2017 Aug; 26(4):866-877. PubMed ID: 28127677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.
    Eccles DM; Mitchell G; Monteiro AN; Schmutzler R; Couch FJ; Spurdle AB; Gómez-García EB;
    Ann Oncol; 2015 Oct; 26(10):2057-65. PubMed ID: 26153499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' Awareness and Utilization of Genetic Services in Texas.
    Diamonstein C; Stevens B; Shahrukh Hashmi S; Refuerzo J; Sullivan C; Hoskovec J
    J Genet Couns; 2018 Aug; 27(4):968-977. PubMed ID: 29280038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician knowledge and attitudes towards molecular genetic (DNA) testing of their patients.
    Hunter A; Wright P; Cappelli M; Kasaboski A; Surh L
    Clin Genet; 1998 Jun; 53(6):447-55. PubMed ID: 9712533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician use of genetic testing for cancer susceptibility: results of a national survey.
    Wideroff L; Freedman AN; Olson L; Klabunde CN; Davis W; Srinath KP; Croyle RT; Ballard-Barbash R
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):295-303. PubMed ID: 12692103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey.
    Mighton C; Clausen M; Shickh S; Baxter NN; Scheer A; Sebastian A; Muir SM; Kim THM; Glogowski E; Schrader KA; Regier DA; Kim RH; Lerner-Ellis J; Bayoumi AM; Thorpe KE; Bombard Y
    Genet Med; 2023 May; 25(5):100819. PubMed ID: 36919843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.
    Scherr CL; Lindor NM; Malo TL; Couch FJ; Vadaparampil ST
    Clin Genet; 2015 Dec; 88(6):523-9. PubMed ID: 25640009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence Variants of Uncertain Significance: What to Do When Genetic Test Results Are Not Definitive.
    Greenblatt MS
    Surg Oncol Clin N Am; 2015 Oct; 24(4):833-46. PubMed ID: 26363543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical Factors.
    Bennett JS; Bernhardt M; McBride KL; Reshmi SC; Zmuda E; Kertesz NJ; Garg V; Fitzgerald-Butt S; Kamp AN
    Pediatr Cardiol; 2019 Dec; 40(8):1679-1687. PubMed ID: 31535183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Clinical Practices Related to Variants of Uncertain Significance Results in Inherited Cardiac Arrhythmia and Inherited Cardiomyopathy Genes.
    Muller RD; McDonald T; Pope K; Cragun D
    Circ Genom Precis Med; 2020 Aug; 13(4):e002789. PubMed ID: 32522017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.
    Johnson LM; Valdez JM; Quinn EA; Sykes AD; McGee RB; Nuccio R; Hines-Dowell SJ; Baker JN; Kesserwan C; Nichols KE; Mandrell BN
    Cancer; 2017 Jun; 123(12):2352-2359. PubMed ID: 28192596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are providers prepared for genomic medicine: interpretation of Direct-to-Consumer genetic testing (DTC-GT) results and genetic self-efficacy by medical professionals.
    McGrath SP; Walton N; Williams MS; Kim KK; Bastola K
    BMC Health Serv Res; 2019 Nov; 19(1):844. PubMed ID: 31760949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.
    Balmaña J; Digiovanni L; Gaddam P; Walsh MF; Joseph V; Stadler ZK; Nathanson KL; Garber JE; Couch FJ; Offit K; Robson ME; Domchek SM
    J Clin Oncol; 2016 Dec; 34(34):4071-4078. PubMed ID: 27621404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reclassification of
    Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW
    J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.